These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 7513467

  • 1. Acceptance of donor-specific islet allografts in rat by intraportal preimmunization with islets and FK 506.
    Yasunami Y, Ryu S, Ueki M, Arima T, Ikeda S, Kamei T.
    Transplant Proc; 1994 Apr; 26(2):722. PubMed ID: 7513467
    [No Abstract] [Full Text] [Related]

  • 2. Long-term survival of Wistar-Furth islet allografts in Lewis rats is associated with spontaneously tolerated orthotopic liver allografts.
    Wan X, Yu W, Yang H, al-Abdullah I, Coddington D, Bitter-Suermann H, Wright JR.
    Transplant Proc; 1994 Apr; 26(2):723-4. PubMed ID: 8171625
    [No Abstract] [Full Text] [Related]

  • 3. Long-term survival of islet allografts in diabetic rats treated with FK 506.
    Tze WJ, Tai J, Cheung SS, Murase N, Ricordi C, Starzl TE.
    Transplant Proc; 1991 Dec; 23(6):3208-10. PubMed ID: 1721411
    [No Abstract] [Full Text] [Related]

  • 4. Induction of donor-specific unresponsiveness in rat islet allografts by FK 506.
    Yasunami Y, Ryu S, Ueki M, Konomi K.
    Transplant Proc; 1992 Jun; 24(3):1037. PubMed ID: 1376510
    [No Abstract] [Full Text] [Related]

  • 5. Prolongation of islet allografts by pretreatment with intrathymic UV-B donor spleen cells.
    Jin MX, Chowdhury NC, James T, Engelstad K, Hardy MA, Oluwole SF.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):291. PubMed ID: 8438304
    [No Abstract] [Full Text] [Related]

  • 6. Injection of bone marrow cells into the thymus to achieve tolerance in an islet xenotransplant (human-to-rat) model.
    Dellagiacoma G, Rossi M, Castagna MT, Radin S, Vecchioni R.
    Transplant Proc; 1994 Jun; 26(3):1114-5. PubMed ID: 8029850
    [No Abstract] [Full Text] [Related]

  • 7. Failure of intrathymic induction of tolerance in outbred rat strains.
    Weide LG.
    Transplant Proc; 1994 Dec; 26(6):3327-8. PubMed ID: 7998157
    [No Abstract] [Full Text] [Related]

  • 8. Intraportal FK 506 improves intrahepatic islet allograft survival.
    Wang X, Berezniak R, Tafra L, Posselt A, Barker CF, Dafoe DC.
    Transplant Proc; 1991 Dec; 23(6):3211-2. PubMed ID: 1721412
    [No Abstract] [Full Text] [Related]

  • 9. Prevention of immune rejection in rat islet allografts by continuous SC administration of FK 506 using a mini-osmotic pump.
    Ryu S, Yasunami Y.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):760. PubMed ID: 1703710
    [No Abstract] [Full Text] [Related]

  • 10. FK 506--an effective immunosuppressant in achieving long-term functional islet allograft survival in diabetic rats.
    Tze WJ, Tai J, Cheung SS, Ricordi C, Murase N, Starzl TE.
    Transplant Proc; 1992 Jun; 24(3):1034-6. PubMed ID: 1376509
    [No Abstract] [Full Text] [Related]

  • 11. The effect of short-term FK 506 therapy on pancreas transplantation in rats.
    Ohtsuka S, Hayashi S, Sato E, Tanaka Y, Hachisuka T, Haba T, Taira N, Orihara A, Uchida K, Kano T.
    Transplant Proc; 1991 Dec; 23(6):3217-8. PubMed ID: 1721413
    [No Abstract] [Full Text] [Related]

  • 12. Intrathymic xenogeneic pancreatic islet transplantation--induction of donor-specific unresponsiveness by MHC class II peptides.
    Zeng Y, Torres M, Wang Y, Montag A, Thistlethwaite JR.
    Transplant Proc; 1995 Feb; 27(1):176-7. PubMed ID: 7878961
    [No Abstract] [Full Text] [Related]

  • 13. Immunosuppressive and diabetogenic effect of FK 506 on pancreatic islet xenotransplantation.
    Yumiba T, Chui AK, Hibbins M, Stewart H, Hawthorne WJ, Chapman JR, Allen R, O'Connell PJ.
    Transplant Proc; 1995 Jun; 27(3):2181-2. PubMed ID: 7540780
    [No Abstract] [Full Text] [Related]

  • 14. Tolerance of islet allografts induced by orthotopic liver transplantation.
    Sawada T, Asanuma Y, Furuya T, Saito K, Koyama K.
    J Surg Res; 1999 Aug; 85(2):209-16. PubMed ID: 10423321
    [Abstract] [Full Text] [Related]

  • 15. Local immunologic factors determine the occurrence of primary nonfunction of islet xenografts.
    Marquet RL, Bouwman E, Bonthuis F, Wolvekamp MC, Kouwenhoven E, van Rooijen N, Scheringa M, Ijzermans JN.
    Transplant Proc; 1994 Apr; 26(2):766-7. PubMed ID: 8171654
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of the immunosuppressive activity of FK 506 in rat islet allografts.
    Yasunami Y, Ryu S, Kamei T.
    Transplant Proc; 1990 Apr; 22(2):875. PubMed ID: 1691557
    [No Abstract] [Full Text] [Related]

  • 17. Islet xenografts in mice and rats: I. Exocrine tissue is detrimental to engraftment and survival of human islet xenografts.
    Nicolae M, Ketchum RJ, Jahr H, Janoff H, Brayman KL.
    Transplant Proc; 1994 Apr; 26(2):774. PubMed ID: 8171657
    [No Abstract] [Full Text] [Related]

  • 18. Primary nonfunction of porcine islets of Langerhans in the thymus of diabetic rats without immunosuppression.
    de Villa VH, Cienfuegos JA, Hernandez JL, Pardo F, Benito C, Balen E, Saez E, Alava E.
    Transplant Proc; 1992 Dec; 24(6):2984-5. PubMed ID: 1466024
    [No Abstract] [Full Text] [Related]

  • 19. Augmented survival of purified islet xeno- and allografts with reduced numbers.
    Gotoh M, Maki T, Porter J, Monaco AP.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):984. PubMed ID: 3152654
    [No Abstract] [Full Text] [Related]

  • 20. Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide.
    Rastellini C, Cicalese L, Leach R, Braun M, Fung JJ, Starzl TE, Rao AS.
    Transplant Proc; 1999 Feb; 31(1-2):646-7. PubMed ID: 10083278
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.